Startup · $480.4k raised
Developing PBT2, a small molecule therapeutic for community-acquired bacterial pneumonia
Melbourne, VIC
Programs: CSIRO (ON Accelerate 9)
Every investor coverage indicates participated in a round Elemental Therapeutics raised.
| Investor | Rounds | Invested |
|---|---|---|
| Australian Economic Accelerator | Grant | - |
| CSIRO | Accelerator | - |
Companies Elemental Therapeutics acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Ella Casale | Founder | Business News Australia, SmartCompany |
Stories naming Elemental Therapeutics. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
CSIRO's ninth ON accelerator cohort of eleven research teams has completed the program, with three members winning grants, two filing patents, and individual awards announced.
CSIRO's ON Accelerate program presents its ninth intake of eleven research startups, drawn from universities nationwide and the agency itself, spanning biotech, healthcare and sustainability, at a Melbourne showcase.